Low- vs High-Dose 5-FU in Triplet Chemotherapy Plus Bevacizumab for Patients With Colorectal Cancer.

ABSTRACT:

SUBMITTER: Chapin WJ 

PROVIDER: S-EPMC11292450 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature